Try our beta test site
98 studies found for:    Open Studies | "Nephritis"
Show Display Options
Rank Status Study
21 Not yet recruiting Aurinia Renal Response in Active Lupus With Orelvo (Voclosporin)
Condition: Lupus Nephritis
Interventions: Drug: Voclosporin;   Drug: Placebo Oral Capsule
22 Recruiting The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: MMF-MMF;   Drug: CTX-AZA
23 Recruiting Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
Conditions: Nephritis;   Lupus
Interventions: Drug: Leflunomide;   Drug: Azathioprine
24 Recruiting The Research of Standard Diagnosis and Treatment for HSPN in Children
Condition: Henoch-Schoenlein Purpura Nephritis
Interventions: Drug: Prednisone;   Drug: Cyclophosphamide(CTX);   Drug: Mycophenolate mofetil(MMF);   Drug: Leflunomide(LEF);   Drug: Angiotensin-converting enzyme inhibitor(ACEI);   Drug: Methylprednisolone
25 Recruiting The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children
Condition: Henoch-Schoenlein Purpura Nephritis
Interventions: Drug: Prednisone;   Drug: ACEI
26 Recruiting The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear
Condition: Lupus Nephritis
Intervention: Drug: mycophenolic acid
27 Recruiting CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Blisibimod;   Drug: Placebo
28 Recruiting Prediction of Outcome of Lupus Nephritis
Condition: Systemic Lupus Erythematosus
Intervention: Other: Serum collection
29 Recruiting Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721
Conditions: IgAN;   Lupus Nephritis;   MN;   C3G
Interventions: Biological: OMS721;   Other: Vehicle (D5W)
30 Recruiting ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis
Condition: SLE Glomerulonephritis Syndrome, WHO Class V
Intervention: Drug: Acthar gel
31 Not yet recruiting Detection of Annexin A2 in Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus (SLE);   Lupus Nephritis
Intervention: Other: ANXA2
32 Recruiting Biomarker for Patient With Alport Disease or Highly Suspected for Alport Disease
Conditions: Nephritis, Hereditary;   Alport Syndrome;   Alport Syndrome, Autosomal Dominant;   Alport Syndrome, Autosomal Recessive;   Hematuria-Nephropathy-Deafness Syndrome
Intervention:
33 Recruiting Alport Syndrome Treatments and Outcomes Registry
Condition: Alport Syndrome
Intervention:
34 Recruiting Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children
Conditions: Renal Insufficiency;   Infection
Interventions: Drug: Low-dose intravenous cyclophosphamide;   Drug: High-dose intravenous cyclophosphamide
35 Recruiting A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL
Condition: Alport Syndrome
Interventions: Drug: Placebo Oral Capsule;   Drug: Bardoxolone Methyl
36 Recruiting ATHENA: Natural History of Disease Study in Alport Syndrome Patients
Condition: Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2
Intervention:
37 Recruiting Immune System Related Kidney Disease
Conditions: Glomerulonephritis;   Lupus Nephritis;   Membranous Glomerulonephritis;   Autoimmune Disease;   Nephrotic Syndrome
Intervention:
38 Recruiting Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Conditions: Kidney Diseases;   Kidney Failure, Chronic;   Diabetic Nephropathy;   Lupus Nephritis;   Glomerulonephritis, IGA
Intervention:
39 Recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Interventions: Drug: milatuzumab;   Drug: Placebo
40 Recruiting Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome
Condition: Renal Insufficiency, Chronic
Interventions: Drug: Ramipril;   Drug: placebo to ramipril

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.